Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (258) Arrow Down
Filter Results: (258) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (119,604)
    • Faculty Publications  (258)

    Show Results For

    • All HBS Web  (119,604)
      • Faculty Publications  (258)

      Hamermesh, Richard G.Remove Hamermesh, Richard G. →

      Page 1 of 258 Results →
      • (Revised May 2024)
      • Teaching Note

      Lyric Dinner Theater (A) and (B)

      By: Richard G. Hamermesh, Jim Sharpe and Noah Fisher
      This teaching note is associated with HBS cases 813-043 and 813-044. View Details
      Keywords: Turnarounds; Turnaround; Operations Management; Family Business; Family-owned Business; Hiring; Careers; Sales; Operations; Entrepreneurship; Negotiation; Entertainment and Recreation Industry; Saint Louis
      Citation
      Purchase
      Related
      Hamermesh, Richard G., Jim Sharpe, and Noah Fisher. "Lyric Dinner Theater (A) and (B)." Harvard Business School Teaching Note 813-088. (Revised May 2024.)
      • January 17, 2022
      • Article

      Reducing Racial Disparities in Cancer Outcomes

      By: Kathy Giusti and Richard G. Hamermesh
      A disproportionate number of Black patients die from cancer in the United States. A key to addressing this problem is enrolling more Black patients in clinical trials. A strategy consisting of these three parts can help accomplish this goal: 1) centralize information... View Details
      Keywords: Cancer Trials; Racial Disparity; Health Testing and Trials; Race; Strategy
      Citation
      Read Now
      Related
      Giusti, Kathy, and Richard G. Hamermesh. "Reducing Racial Disparities in Cancer Outcomes." Harvard Business Review (website) (January 17, 2022).
      • June 11, 2021
      • Article

      Addressing Demographic Disparities in Clinical Trials

      By: Kathy Giusti, Richard G. Hamermesh and Mark Krasnow
      Disparities in health care are not just limited to the delivery of care. They also exist in the way that clinical trials are structured. Women, people of color, and the elderly often are not adequately represented. This article offers three strategies for addressing... View Details
      Keywords: Health Testing and Trials; Demographics
      Citation
      Find at Harvard
      Register to Read
      Related
      Giusti, Kathy, Richard G. Hamermesh, and Mark Krasnow. "Addressing Demographic Disparities in Clinical Trials." Harvard Business Review Digital Articles (June 11, 2021).
      • September 30, 2020
      • Article

      How Nonprofit Foundations Can Sustainably Fund Disease Research

      By: Richard G. Hamermesh and Kathy Giusti
      Citation
      Find at Harvard
      Register to Read
      Related
      Hamermesh, Richard G., and Kathy Giusti. "How Nonprofit Foundations Can Sustainably Fund Disease Research." Harvard Business Review Digital Articles (September 30, 2020).
      • August 18, 2020
      • Article

      What It Takes to Lead a Disease Research Foundation

      By: Richard G. Hamermesh and Kathy Giusti
      Citation
      Find at Harvard
      Register to Read
      Related
      Hamermesh, Richard G., and Kathy Giusti. "What It Takes to Lead a Disease Research Foundation." Harvard Business Review Digital Articles (August 18, 2020).
      • June 2020
      • Case

      Breakthroughs at Blueprint Medicines

      By: Richard G. Hamermesh, Kathy Giusti and Susie L. Ma
      Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development... View Details
      Keywords: Precision Medicine; Cancer; Biotechnology; Drug Development; Strategy; Expansion; Science; Genetics; Information Technology; Entrepreneurship; Organizational Culture; Management; Growth and Development; Pharmaceutical Industry; United States; Cambridge; Massachusetts
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., Kathy Giusti, and Susie L. Ma. "Breakthroughs at Blueprint Medicines." Harvard Business School Case 820-001, June 2020.
      • March 6, 2020
      • Article

      How Medical Nonprofits Set Winning Strategy

      By: Kathy Giusti and Richard G. Hamermesh
      Citation
      Find at Harvard
      Read Now
      Related
      Giusti, Kathy, and Richard G. Hamermesh. "How Medical Nonprofits Set Winning Strategy." Harvard Business Review Digital Articles (March 6, 2020).
      • Article

      How Harvard Business School Is Advancing Precision Medicine

      By: Kathy Giusti and Richard G. Hamermesh
      Citation
      Read Now
      Related
      Giusti, Kathy, and Richard G. Hamermesh. "How Harvard Business School Is Advancing Precision Medicine." Journal of Precision Medicine (March 2020).
      • September 2019
      • Case

      Dementia Discovery Fund

      By: Richard G. Hamermesh, Kathy Giusti and Sarah Gulick
      The case is set in March 2019, and tells the story of the founding of the Dementia Discovery Fund (DDF). The idea for the fund began in 2015, when then-Prime Minister David Cameron spoke about the importance of making breakthroughs in dementia research, and pledged... View Details
      Keywords: Venture Capital; Investment Funds; Mission and Purpose; Recruitment; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Boston; Massachusetts; London; England
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., Kathy Giusti, and Sarah Gulick. "Dementia Discovery Fund." Harvard Business School Case 820-045, September 2019.
      • July 2019 (Revised July 2019)
      • Teaching Note

      Intermountain Healthcare: Pursuing Precision Medicine

      By: Richard G. Hamermesh, Robert S. Huckman and Julia Kelley
      Citation
      Purchase
      Related
      Hamermesh, Richard G., Robert S. Huckman, and Julia Kelley. "Intermountain Healthcare: Pursuing Precision Medicine." Harvard Business School Teaching Note 820-019, July 2019. (Revised July 2019.)
      • June 4, 2019
      • Article

      Finding the Sweet Spot: Why Industry, Nonprofits Should (or Can) Collaborate on Master Protocols

      By: Richard G. Hamermesh, Kathy Giusti and Bradley Smith
      Citation
      Read Now
      Related
      Hamermesh, Richard G., Kathy Giusti, and Bradley Smith. "Finding the Sweet Spot: Why Industry, Nonprofits Should (or Can) Collaborate on Master Protocols." Clinical Research News Online (June 4, 2019).
      • 28 Feb 2019
      • Interview

      Pursuing Precision Medicine at Intermountain Healthcare

      By: Richard G. Hamermesh and Brian Kenny
      Citation
      Related
      "Pursuing Precision Medicine at Intermountain Healthcare." Cold Call (podcast), Harvard Business Review Group, February 28, 2019.
      • February 25, 2019
      • Article

      Impact Investing: A New Way to Fund Cures for Cancer

      By: Richard G. Hamermesh and Kathy Giusti
      Citation
      Read Now
      Related
      Hamermesh, Richard G., and Kathy Giusti. "Impact Investing: A New Way to Fund Cures for Cancer." STAT (February 25, 2019).
      • December 12, 2018
      • Article

      Impact Investing Could Accelerate the Fight Against Cancer

      By: Richard G. Hamermesh and Kathryn E. Giusti
      Citation
      Find at Harvard
      Read Now
      Related
      Hamermesh, Richard G., and Kathryn E. Giusti. "Impact Investing Could Accelerate the Fight Against Cancer." Harvard Business Review (website) (December 12, 2018).
      • November 12, 2018
      • Article

      Precision Medicine Has Transformed Cancer Treatment. Here's How to Move It Beyond Oncology

      By: Richard G. Hamermesh and Kathy Giusti
      Citation
      Read Now
      Related
      Hamermesh, Richard G., and Kathy Giusti. "Precision Medicine Has Transformed Cancer Treatment. Here's How to Move It Beyond Oncology." Fortune.com (November 12, 2018).
      • October 4, 2018
      • Article

      Precision Medicine Needs a Business Mindset in Order to Flourish

      By: Richard G. Hamermesh and Kathryn E. Giusti
      Citation
      Read Now
      Related
      Hamermesh, Richard G., and Kathryn E. Giusti. "Precision Medicine Needs a Business Mindset in Order to Flourish." STAT (October 4, 2018).
      • May 2018
      • Case

      The Multiple Myeloma Research Foundation's Answer Fund

      By: Richard G. Hamermesh and Matthew G. Preble
      Keywords: Data Analytics; Customer Focus and Relationships; Customer Relationship Management; Cost vs Benefits; Investment Return; Health Care and Treatment; Innovation Leadership; Intellectual Property; Knowledge Sharing; Knowledge Dissemination; Leadership; Leading Change; Resource Allocation; Goals and Objectives; Marketing Communications; Performance; Programs; Projects; Business and Community Relations; Business and Stakeholder Relations; Networks; Partners and Partnerships; Research and Development; Genetics; Behavior; Motivation and Incentives; Social and Collaborative Networks; Nonprofit Organizations; Strategy; Health Industry; Pharmaceutical Industry; Biotechnology Industry; United States
      Citation
      Educators
      Related
      Hamermesh, Richard G., and Matthew G. Preble. "The Multiple Myeloma Research Foundation's Answer Fund." Harvard Business School Case 818-045, May 2018.
      • Article

      Master Protocols in Oncology: A Review of the Landscape

      By: Bradley Smith, Kathy Giusti, Richard G. Hamermesh and Dixie-Lee Esseltine
      Citation
      Find at Harvard
      Read Now
      Related
      Smith, Bradley, Kathy Giusti, Richard G. Hamermesh, and Dixie-Lee Esseltine. "Master Protocols in Oncology: A Review of the Landscape." Applied Clinical Trials 27, no. 5 (May 2018).
      • April 2018
      • Case

      Hawk Electronics, Inc.

      By: Richard G. Hamermesh and John J. Lafkas
      Hawk Electronics ("Hawk") presents the problems that a company can encounter when its divisions have distinct strategies, especially when one division has been favored at another's expense. It also highlights how such problems can reflect cognitive biases, which... View Details
      Keywords: Business Divisions; Resource Allocation; Strategy; Innovation and Management
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., and John J. Lafkas. "Hawk Electronics, Inc." Harvard Business School Brief Case 918-521, April 2018.
      • April 2018
      • Teaching Note

      Hawk Electronics, Inc. (Brief Case)

      By: Richard G. Hamermesh and John J. Lafkas
      Teaching Note for HBS Brief Case 918-521. View Details
      Citation
      Purchase
      Related
      Hamermesh, Richard G., and John J. Lafkas. "Hawk Electronics, Inc. (Brief Case)." Harvard Business School Teaching Note 918-522, April 2018.
      • 1
      • 2
      • …
      • 12
      • 13
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.